OneSource Specialty Pharma shares jump 14% after Q2 results; recover 50% from recent lows
60-Word AI Digest
OneSource Specialty Pharma shares rose nearly 14% after the company reported Q2 revenue growth of 37% year-on-year and adjusted profit after tax of ₹93.7 crore. The company maintained its FY28 targets and expects expanded drug-device combination capacity to support future growth.
Key Takeaways
- OneSource Specialty Pharma shares rose nearly 14% after the company reported Q2 revenue growth of 37% year-on-year and adjusted profit after tax of ₹93.7 crore.
- The company maintained its FY28 targets and expects expanded drug-device combination capacity to support future growth.
- Full details and original dispatch available below.
OneSource Specialty Pharma shares rose nearly 14% after the company reported Q2 revenue growth of 37% year-on-year and adjusted profit after tax of ₹93.7 crore. The company maintained its FY28 targets and expects expanded drug-device combination capacity to support future growth.
Original Publisher Attribution
This summary was curated from Livemint.